GO:0004817 cysteine-tRNA ligase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004817 cysteine-tRNA ligase activity catalyzes ATP + L-cysteine + tRNA(Cys) = AMP + diphosphate + L-cysteinyl-tRNA(Cys), attaching cysteine to its cognate tRNA for protein synthesis.
• The canonical enzyme is cysteinyl-tRNA synthetase (CARS1 in humans, CysRS in bacteria), a class I aminoacyl-tRNA synthetase; some archaea and bacteria instead synthesize Cys-tRNA(Cys) by an indirect, RNA-dependent route.
• Cysteine activation and tRNA charging were measured directly in human cells, with Michaelis-Menten constants determined for cysteinyl-tRNA synthetase.
• Mitochondrial CARS2 supports supersulfide/persulfide production and protects retinal cells from excitotoxic death, linking this activity to redox biology.
• Persulfide biosynthesis is evolutionarily conserved and intersects with cysteine-tRNA ligase-dependent pathways across organisms.
• Loss or mutation of this activity impairs translation fidelity and mitochondrial function, making it a target for knockout, point-mutation, knock-in and overexpression CRISPR models.
Description
GO:0004817 cysteine-tRNA ligase activity is the molecular function that covalently attaches the amino acid L-cysteine to its cognate transfer RNA, tRNA(Cys), in the first step of decoding cysteine codons during translation. The reaction consumes ATP and releases AMP and diphosphate, producing L-cysteinyl-tRNA(Cys), the substrate delivered to the ribosome for protein synthesis. Because cysteine is redox-active and structurally unique, accurate charging by this activity is essential for proteome fidelity and for cysteine-dependent processes such as iron-sulfur cluster assembly and persulfide metabolism. Researchers study cysteine-tRNA ligase activity to understand translation, mitochondrial biology and redox signaling. In humans, the cytosolic and mitochondrial enzymes are encoded by CARS1 and CARS2, and mitochondrial CARS2 has been shown to protect retinal cells from excitotoxic death via enhanced supersulfide production. In cultured cystinotic cells, the specific activity of cysteinyl-tRNA synthetase and the kinetic constants of the enzyme were determined directly, providing an early quantitative framework for this activity in human disease. Comparative genomics revealed that not all organisms use the canonical direct route: some archaea and bacteria lack a normal cysteine-tRNA synthetase and instead synthesize cysteinyl-tRNA(Cys) by an indirect pathway, including a prolyl-tRNA synthetase that can charge tRNA(Pro) with cysteine. This diversity makes GO:0004817 a useful entry point for evolutionary, structural and therapeutic studies.
cysteine-tRNA ligase activity At A Glance
| GO ID | GO:0004817 |
|---|---|
| GO term | cysteine-tRNA ligase activity |
| Ontology | molecular_function |
| Synonym | cysteinyl-tRNA synthetase activity; cysteine translase activity; cysteinyl-transfer ribonucleate synthetase activity; cysteinyl-transferRNA synthetase activity; L-cysteine:tRNACys ligase (AMP-forming) |
| Major function | Catalyzes ATP + L-cysteine + tRNA(Cys) = AMP + diphosphate + L-cysteinyl-tRNA(Cys), charging tRNA(Cys) for translation |
| Reaction type | Aminoacyl-tRNA synthetase (class I) two-step aminoacylation with ATP consumption |
| Cognate substrates | L-cysteine, tRNA(Cys), ATP |
| Products | L-cysteinyl-tRNA(Cys), AMP, diphosphate |
| Representative human genes | CARS1 (cytosolic), CARS2 (mitochondrial) |
| Alternative route | Indirect RNA-dependent cysteine biosynthesis in some archaea and bacteria |
What Is GO:0004817?
In plain terms, cysteine-tRNA ligase activity is the catalytic function that loads the amino acid cysteine onto its matching tRNA molecule. According to the QuickGO definition, it catalyzes the reaction ATP + L-cysteine + tRNA(Cys) = AMP + diphosphate + L-cysteinyl-tRNA(Cys). This is a two-step aminoacylation reaction: cysteine is first activated with ATP to form an aminoacyl-adenylate, and the activated cysteine is then transferred to the 3' end of tRNA(Cys), yielding cysteinyl-tRNA(Cys) plus AMP and diphosphate. The activity is synonymous with cysteinyl-tRNA synthetase activity, cysteine translase activity and L-cysteine:tRNACys ligase (AMP-forming).
Why Is cysteine-tRNA ligase activity Important in Cell Biology?
Cysteine-tRNA ligase activity sits at the intersection of translation, redox homeostasis and mitochondrial function. Accurate charging of tRNA(Cys) is required for incorporation of cysteine into newly synthesized proteins, and the enzyme itself is a node for cysteine-dependent persulfide and supersulfide production that influences cell survival under stress. Because cysteine is chemically reactive and central to antioxidant defense, defects in this activity can perturb both protein synthesis and redox signaling, and the enzyme has been quantified in human disease contexts such as cystinosis. In addition, the existence of indirect cysteine-tRNA(Cys) synthesis pathways in diverse microbes highlights this activity as a model for studying the evolution of the genetic code and for identifying organism-specific vulnerabilities.
• Provides the only direct route to L-cysteinyl-tRNA(Cys) for ribosomal protein synthesis in many organisms.
• Supports mitochondrial function and cell fate decisions in hematopoietic progenitors.
• Contributes to supersulfide/persulfide production that protects retinal cells from excitotoxic death.
• Links translation to redox biology through conserved persulfide biosynthesis pathways.
• Has been kinetically characterized in human cystinotic cells, connecting activity to a lysosomal storage disorder.
• Shows evolutionary diversity: some archaea and bacteria use indirect cysteine-tRNA(Cys) synthesis.
• Can be moonlighted by non-cognate synthetases, as shown for a prolyl-tRNA synthetase that charges tRNA(Pro) with cysteine.
• Represents a tractable target for CRISPR knockout, point-mutation, knock-in and overexpression studies.
• Relevant to angiogenesis and vascular function through hydropersulfide biology.
• Serves as a model system for aminoacyl-tRNA synthetase mechanism and tRNA identity rules.
Molecular Mechanism of cysteine-tRNA ligase activity
Substrate binding and cysteine activation
In simple terms: The enzyme first grabs cysteine and ATP, then activates cysteine so it can be attached to tRNA.
Cysteine-tRNA ligase activity begins with binding of L-cysteine and ATP in the enzyme active site. The enzyme catalyzes formation of a cysteinyl-adenylate intermediate with release of diphosphate, a classic class I aminoacyl-tRNA synthetase activation step. Kinetic characterization of cysteinyl-tRNA synthetase in cultured cystinotic cells provided Michaelis-Menten constants for this activity, establishing quantitative parameters for cysteine activation in human cells.
tRNA(Cys) recognition and aminoacyl transfer
In simple terms: The activated cysteine is then transferred onto the correct tRNA, the one that reads cysteine codons.
After activation, the cysteinyl moiety is transferred to the 3' end of tRNA(Cys), producing L-cysteinyl-tRNA(Cys) and releasing AMP. This step depends on specific recognition of tRNA(Cys) identity elements by the synthetase. In some archaea and bacteria that lack a normal cysteine-tRNA synthetase, cysteinyl-tRNA(Cys) is instead synthesized by an indirect, RNA-dependent pathway, demonstrating that tRNA recognition and aminoacyl transfer can be uncoupled from direct cysteine activation.
Indirect and non-canonical routes to Cys-tRNA(Cys)
In simple terms: Some organisms make Cys-tRNA(Cys) without a dedicated cysteine-tRNA synthetase, using other enzymes and chemical conversions.
Methanocaldococcus jannaschii prolyl-tRNA synthetase can charge tRNA(Pro) with cysteine, showing that a non-cognate synthetase can mischarge tRNA with cysteine under certain conditions. In organisms whose genomes lack the normal cysteine-tRNA synthetase, an indirect pathway generates cysteinyl-tRNA(Cys), and RNA-dependent cysteine biosynthesis has been demonstrated in archaea. These findings expand the functional landscape of GO:0004817 beyond the canonical direct reaction.
Cofactors, redox context and regulation
In simple terms: The activity is influenced by the cell's redox state and by mitochondrial metabolism.
Cysteine-tRNA ligase activity operates in a redox-rich environment because cysteine itself is redox-active. Mitochondrial CARS2 enhances supersulfide production and protects against excitotoxic retinal cell death, linking the activity to redox signaling. Persulfide biosynthesis is evolutionarily conserved across organisms, and cysteine-tRNA ligase-dependent pathways intersect with this chemistry. Hydropersulfides also promote angiogenesis and preserve vascular function, indicating that cysteine-related sulfur metabolism has broad physiological roles. Mitochondria regulate cell fate decisions of megakaryocyte-erythroid progenitors, providing a context in which mitochondrial translation and cysteine handling influence differentiation.
Key Genes Involved in GO:0004817 cysteine-tRNA ligase activity
The genes and proteins below represent the canonical and non-canonical factors associated with cysteine-tRNA ligase activity, including human cytosolic and mitochondrial enzymes, bacterial and archaeal synthetases, and indirect pathway components.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CARS1 | Human cytosolic cysteinyl-tRNA synthetase; charges tRNA(Cys) with cysteine | Core enzyme for cytosolic translation; target for knockout and point-mutation studies |
| CARS2 | Human mitochondrial cysteinyl-tRNA synthetase; supports mitochondrial translation and supersulfide production | Protects retinal cells from excitotoxic death; mitochondrial disease and neurodegeneration models |
| CysRS (bacterial) | Canonical bacterial cysteine-tRNA synthetase | Antibacterial target; evolutionary comparisons of aminoacylation |
| ProRS (M. jannaschii) | Prolyl-tRNA synthetase that can charge tRNA(Pro) with cysteine | Demonstrates non-cognate cysteine charging and tRNA flexibility |
| tRNA(Cys) | Cognate tRNA substrate for cysteine-tRNA ligase activity | Identity element studies and charging assays |
| Indirect pathway enzymes (archaea) | Generate Cys-tRNA(Cys) without a normal cysteine-tRNA synthetase | Model for RNA-dependent cysteine biosynthesis |
| Indirect pathway enzymes (bacteria) | Synthesize cysteinyl-tRNA(Cys) in genomes lacking canonical CysRS | Comparative genomics and antimicrobial discovery |
| Persulfide biosynthesis enzymes | Produce persulfides/supersulfides linked to cysteine metabolism | Redox biology and vascular function studies |
| Mitochondrial translation machinery | Coordinates with CARS2 for mitochondrial protein synthesis | Cell fate decisions in hematopoietic progenitors |
| Cysteine transport and metabolism genes | Supply cysteine for charging and redox pathways | Cystinosis and metabolic disease models |
| tRNA modification enzymes | Modify tRNA(Cys) and influence charging efficiency | Translation fidelity and synthetase recognition studies |
| Aminoacyl-tRNA synthetase editing domains | Ensure fidelity of cysteine attachment | Mechanistic and structural studies |
| Redox regulators (e.g., glutathione system) | Modulate cysteine availability and sulfur metabolism | Oxidative stress and angiogenesis research |
| Mitochondrial dynamics genes | Influence mitochondrial CARS2 function and cell fate | Megakaryocyte-erythroid progenitor differentiation |
| Excitotoxicity signaling genes | Context for CARS2 protective effects in retina | Retinal neurodegeneration models |
| Hydropersulfide-producing enzymes | Generate signaling sulfur species | Vascular function and angiogenesis |
How Is cysteine-tRNA ligase activity Regulated?
Cysteine-tRNA ligase activity is regulated at multiple levels. Substrate availability, especially cysteine and ATP, directly controls flux through the reaction, and the enzyme's kinetic constants define its responsiveness to substrate concentration. In mitochondria, CARS2 activity is coupled to supersulfide production, so redox state and mitochondrial metabolism influence its protective functions. Persulfide biosynthesis pathways are evolutionarily conserved and intersect with cysteine-tRNA ligase-dependent sulfur chemistry, providing a broader regulatory network. Mitochondrial regulation of cell fate decisions in megakaryocyte-erythroid progenitors further indicates that this activity is embedded in metabolic and differentiation signaling. Hydropersulfide biology also links cysteine-related sulfur metabolism to vascular function, suggesting redox-sensitive regulation.
cysteine-tRNA ligase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CARS1 | Cystinosis-related cysteine metabolism and translation defects | Patient-derived cystinotic cells and CARS1 knockout cell lines |
| CARS2 | Retinal excitotoxicity and neurodegeneration | CARS2 knockout or point-mutation retinal cell models |
| CARS2 | Mitochondrial dysfunction and hematopoietic cell fate | Megakaryocyte-erythroid progenitor differentiation assays |
| Persulfide pathway genes | Vascular dysfunction and impaired angiogenesis | Endothelial cell models with hydropersulfide modulation |
| tRNA(Cys) and synthetase editing factors | Translation fidelity and proteostasis | Reporter assays and tRNA charging measurements |
Cystinosis and lysosomal cysteine handling
Cultured cystinotic cells were used to measure the specific activity of cysteinyl-tRNA synthetase and the Michaelis-Menten constants for the enzyme, directly connecting cysteine-tRNA ligase activity to a human lysosomal storage disorder. These measurements established that cysteine activation can be quantified in patient-derived cells and provided a foundation for understanding how disturbed cysteine homeostasis affects translation.
Retinal excitotoxicity and neurodegeneration
Mitochondrial cysteinyl-tRNA synthetase 2 (CARS2) protects against excitotoxic retinal cell death via enhanced supersulfide production. This links GO:0004817 to neurodegeneration and suggests that mitochondrial cysteine charging supports redox defense in neurons. Loss of CARS2 function may therefore sensitize retinal cells to excitotoxic injury.
Redox signaling, angiogenesis and vascular function
Hydropersulfides promote angiogenesis and preserve vascular function, and persulfide biosynthesis is conserved across organisms. Because cysteine-tRNA ligase activity supplies cysteine for these sulfur pathways, its dysfunction could perturb vascular redox signaling. This positions the activity within cardiovascular and angiogenesis research.
Mitochondrial metabolism and hematopoietic cell fate
Mitochondria regulate cell fate decisions of megakaryocyte-erythroid progenitors, and mitochondrial translation depends on charged mitochondrial tRNAs. CARS2-mediated cysteine charging is therefore relevant to blood cell differentiation and mitochondrial disease. Experimental models that perturb CARS2 can test whether cysteine-tRNA ligase activity is required for progenitor fate.
From cysteine-tRNA ligase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CARS1 required for cytosolic translation and cell viability? | CARS1 knockout cell line |
| Does a disease-associated CARS2 variant impair mitochondrial charging? | CARS2 point-mutation knock-in cell line |
| Can tagged CARS2 reveal mitochondrial localization and interactions? | CARS2 knock-in with epitope tag |
| Does CARS2 overexpression protect against excitotoxicity? | CARS2 overexpression in retinal neurons |
| Which genes buffer loss of cysteine-tRNA ligase activity? | CRISPR library screening in CARS1/CARS2 knockout background |
| How does cysteine-tRNA ligase activity affect progenitor fate? | Megakaryocyte-erythroid progenitor differentiation model |
How to Study the cysteine-tRNA ligase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Aminoacylation assay | Cysteine incorporation into tRNA(Cys) | Enzyme kinetics and inhibitor testing |
| Michaelis-Menten analysis | Substrate affinity and catalytic parameters | Characterizing cysteinyl-tRNA synthetase variants |
| CRISPR knockout | Loss-of-function phenotypes | Testing CARS1/CARS2 requirement |
| Point-mutation knock-in | Effect of specific disease variants | CARS2 variant functional studies |
| Overexpression | Gain-of-function and protection assays | Excitotoxicity and redox protection |
| Redox/sulfur profiling | Persulfide and supersulfide levels | Linking activity to redox signaling |
| Comparative genomics | Presence/absence of canonical CysRS | Identifying indirect pathways |
| tRNA charging reporter | Translation fidelity and tRNA status | Proteostasis and stress studies |
Aminoacylation and kinetic assays
Direct measurement of cysteine-tRNA ligase activity uses aminoacylation assays that quantify incorporation of radiolabeled or fluorescent cysteine into tRNA(Cys). Michaelis-Menten constants for cysteinyl-tRNA synthetase were determined in cultured cystinotic cells, providing a template for kinetic characterization in other models.
CRISPR-based genetic perturbation
Knockout, point-mutation, knock-in and overexpression models allow causal testing of CARS1 and CARS2 functions. Such models can be combined with mitochondrial and redox readouts to link cysteine-tRNA ligase activity to phenotypes such as excitotoxic retinal cell death and progenitor differentiation.
Redox and sulfur metabolite profiling
Because cysteine-tRNA ligase activity intersects with persulfide and supersulfide production, sulfur metabolite profiling and redox sensors are used to measure downstream effects. Persulfide biosynthesis is conserved and can be monitored across organisms, and hydropersulfide effects on angiogenesis can be assessed in vascular models.
Comparative genomics and evolutionary analysis
Genomes lacking a normal cysteine-tRNA synthetase can be identified by comparative genomics, and indirect cysteine-tRNA(Cys) synthesis can be tested biochemically. This approach revealed RNA-dependent cysteine biosynthesis in archaea and alternative routes in bacteria, and non-cognate charging by prolyl-tRNA synthetase.
How CRISPR Can Be Used to Study GO:0004817 cysteine-tRNA ligase activity
Knockout
CRISPR knockout of CARS1 or CARS2 eliminates cysteine-tRNA ligase activity, enabling tests of its requirement for cytosolic and mitochondrial translation. Knockout models can reveal synthetic lethal interactions and compensatory pathways, and are useful for studying cell fate decisions in progenitors and retinal cell survival.
Point Mutation
Point-mutation knock-in introduces specific amino acid substitutions into CARS1 or CARS2 to model disease variants or catalytic residues. Such models separate catalytic activity from non-canonical functions, such as supersulfide production by CARS2, and allow kinetic comparison with wild-type enzyme.
Knock-in
Tagged knock-in of CARS1 or CARS2 enables localization, interaction and proximity-labeling studies without overexpression artifacts. This is valuable for defining where cysteine-tRNA ligase activity operates within cells and mitochondria.
Overexpression
Overexpression of CARS2 or CARS1 can test gain-of-function phenotypes, including protection against excitotoxic stress and enhanced sulfur metabolite production. Overexpression models also help identify dose-dependent effects on translation and redox balance.
How EDITGENE Supports cysteine-tRNA ligase activity Research
Researchers studying cysteine-tRNA ligase activity-related genes often need to determine whether a candidate gene is causally involved in translation, mitochondrial function or redox biology. Rigorous causal inference requires well-controlled genetic models that isolate the contribution of cysteine-tRNA ligase activity from secondary effects.
Contact EDITGENE today to design your custom CRISPR model for cysteine-tRNA ligase activity research.
Frequently Asked Questions About cysteine-tRNA ligase activity
What is cysteine-tRNA ligase activity?
Cysteine-tRNA ligase activity (GO:0004817) catalyzes ATP + L-cysteine + tRNA(Cys) = AMP + diphosphate + L-cysteinyl-tRNA(Cys), attaching cysteine to its cognate tRNA for protein synthesis.
What genes are involved in cysteine-tRNA ligase activity?
The main human genes are CARS1 (cytosolic) and CARS2 (mitochondrial); bacterial and archaeal systems use CysRS and, in some cases, indirect pathway enzymes.
What is the reaction catalyzed by cysteine-tRNA ligase?
It activates cysteine with ATP to form cysteinyl-adenylate and transfers cysteine to tRNA(Cys), releasing AMP and diphosphate.
Why is cysteine-tRNA ligase activity important for mitochondria?
Mitochondrial CARS2 supports mitochondrial translation and supersulfide production, protecting retinal cells from excitotoxic death.
Do all organisms use the same cysteine-tRNA ligase pathway?
No. Some archaea and bacteria lack a normal cysteine-tRNA synthetase and use indirect, RNA-dependent cysteine biosynthesis.
Can other synthetases charge tRNA with cysteine?
Yes, Methanocaldococcus jannaschii prolyl-tRNA synthetase can charge tRNA(Pro) with cysteine, showing non-cognate charging.
How is cysteine-tRNA ligase activity measured?
Aminoacylation assays quantify cysteine incorporation into tRNA(Cys), and Michaelis-Menten analysis defines kinetic constants.
Is cysteine-tRNA ligase activity linked to disease?
Yes, it has been studied in cystinotic cells and linked to retinal excitotoxicity and redox-related vascular biology.
What CRISPR models are used to study cysteine-tRNA ligase activity?
Knockout, point-mutation, knock-in and overexpression models of CARS1 and CARS2 are used to test causal roles in translation and redox biology.
How does cysteine-tRNA ligase activity relate to persulfides?
Cysteine metabolism intersects with conserved persulfide biosynthesis, and CARS2 enhances supersulfide production.
Conclusion
GO:0004817 cysteine-tRNA ligase activity is a central molecular function that charges tRNA(Cys) with cysteine, supporting translation, mitochondrial function and redox biology. Its canonical and indirect pathways span bacteria, archaea and humans, and its dysfunction has been linked to cystinosis-related cysteine handling, retinal excitotoxicity and vascular redox signaling. Continued work with CRISPR knockout, point-mutation, knock-in and overexpression models will clarify how this activity contributes to health and disease.
References
- 1. Sung E et al.. 2025. Mitochondria regulate the cell fate decisions of megakaryocyte-erythroid progenitors.. Stem Cell Reports 20(12):102720 PMID: 41270746
- 2. Ambrogelly A et al.. 2002. Methanocaldococcus jannaschii prolyl-tRNA synthetase charges tRNA(Pro) with cysteine.. J Biol Chem 277(38):34749-54 PMID: 12130658
- 3. Ogata S et al.. 2023. Persulfide Biosynthesis Conserved Evolutionarily in All Organisms.. Antioxid Redox Signal 39(13-15):983-999 PMID: 37565274
- 4. Waterson JR et al.. 1974. Cysteine activation in cultured cystinotic cells. The specific activity of cysteinyl-tRNA synthetase and tRNACys and the determination of the Michaelis-Menten constants for cysteinyl-tRNA synthetase.. J Clin Invest 54(1):182-7 PMID: 4834888
- 5. Lamb RJ et al.. 2026. Hydropersulfides promote angiogenesis and preserve vascular function.. Redox Biol 94:104192 PMID: 42085865
- 6. Lipman RS et al.. 2000. Synthesis of cysteinyl-tRNA(Cys) by a genome that lacks the normal cysteine-tRNA synthetase.. Biochemistry 39(26):7792-8 PMID: 10869184
- 7. Sauerwald A et al.. 2005. RNA-dependent cysteine biosynthesis in archaea.. Science 307(5717):1969-72 PMID: 15790858
- 8. Chida Y et al.. 2026. Mitochondrial cysteinyl-tRNA synthetase 2 protects against excitotoxic retinal cell death via enhanced supersulfide production.. Free Radic Biol Med 246:69-79 PMID: 41506554
